Study: Abdominal Fat

Have unwanted abdominal fat?

This study is testing a new injectable medication designed to reduce abdominal fat. It was developed as an alternative non-surgical option. The purpose of the trial is to investigate whether the medication is effective and safe. Eligible participants will be reimbursed for their time and travel.

Eligibility criteria:

• 18 years old or older

• Have visible abdominal fat

• Have a BMI between 18.5 and 30 kg/m², and body weight more than 50 kg

• Not currently taking weight loss medication

For details, please contact Daniela Borzillo Tel: (03) 9826 4966 or Email: clinicaltrials@div.net.au

Interested in learning more?

Fill in your details below and we’ll contact you with further information.